GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $123,479 | -30.6% | 148,270 | 0.0% | 0.00% | – |
Q2 2023 | $177,924 | -32.5% | 148,270 | -29.1% | 0.00% | – |
Q1 2023 | $263,428 | -42.2% | 209,070 | -0.4% | 0.00% | – |
Q4 2022 | $455,635 | -81.9% | 209,970 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $2,515,000 | +503.1% | 209,970 | +321.6% | 0.00% | – |
Q2 2022 | $417,000 | -3.5% | 49,800 | 0.0% | 0.00% | – |
Q1 2022 | $432,000 | -23.1% | 49,800 | +0.2% | 0.00% | – |
Q4 2021 | $562,000 | -10.1% | 49,700 | 0.0% | 0.00% | – |
Q3 2021 | $625,000 | +39.2% | 49,700 | -10.1% | 0.00% | – |
Q2 2021 | $449,000 | -64.5% | 55,300 | -59.5% | 0.00% | -100.0% |
Q1 2021 | $1,264,000 | -9.5% | 136,622 | -5.3% | 0.00% | 0.0% |
Q4 2020 | $1,396,000 | -95.1% | 144,322 | -93.7% | 0.00% | -93.3% |
Q3 2020 | $28,646,000 | -0.2% | 2,308,314 | +4.5% | 0.02% | -11.8% |
Q2 2020 | $28,710,000 | +54.0% | 2,208,430 | +20.3% | 0.02% | +30.8% |
Q1 2020 | $18,639,000 | -31.5% | 1,836,375 | +5.5% | 0.01% | -13.3% |
Q4 2019 | $27,212,000 | -11.5% | 1,741,005 | -4.9% | 0.02% | -21.1% |
Q3 2019 | $30,750,000 | -14.5% | 1,831,446 | +13.0% | 0.02% | -13.6% |
Q2 2019 | $35,961,000 | +19.1% | 1,621,319 | +16.4% | 0.02% | +10.0% |
Q1 2019 | $30,185,000 | – | 1,392,941 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |